Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell !!

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Medical Marijuana Inc. MJNA Cannot Sell !!



Cannabis · Hemp · Hanf · Cannabinoids · THC · CBD · Medical · Medicinal ·

FDA · NHI · EMA · JMA · Patient · Patent · License · Audit · Report · SEC ·



MMJ = Medical Marijuana or CBD Hemp !



Medical Marijuana Inc. - Cannot Sell MMJ or CBD Products !!



Seems majority of its Investors mentally very

dependent, that normal commonsense market

considerations are not possible. Just Pumpers

fake oriented !

For example most of them like to believe, that

Registered MMJ or CBD Patients for Pain-Therapy

will pay annually about $ 8000.- to MJNA, when

they at any Pharmacy as even FDA Approved can

get for $ ZERO the principally much more expensive

CBD Sativex which is also killing Pain & Cancer as

it already worldwide does, but FDA Approved the

US Health Insurances completely paying for it !!



100% sure, 99% of Registered Patients are not

willing to pay annually $ 8000.- to MJNA as they

don’t need or not even have the money or with

that money better go for Holiday or do with it

something else in life important, instead of

paying for Companies such as MJNA !



Famous CBD Sativex is now at every US Pharmacy available !!!



MJNA at present has the most exposure and

because of this it gets most affected, but for

fairness its necessary to mention that any MJ

Company with desire to sell MMJ Products get

affected by its None FDA Approved Products

the US Health Insurances Therefore Not Pay !!

MJNA is additionally under SEC Investigations.



Small US MJ Companies not able to change

the Handling of the US Health Insurances !!



This for All Investors to think very well about !



PS : GW Pharmaceuticals the producer of its

patented Sativex, by its owner consortium is

related to Big Global Player Companies with

worldwide annual Revenue of about $ 168 Bn.

This only for knowing with what the small US

MJ Companies really dealing with and to see

the present situation as the beginning only !

For the additional Wellness- Products, there

will be coming Companies as Nestle, Unilever,

RedBull, Etc. also to keep well in mind !!

Its not that simple or easy as Pumpers Think !

Additionally New Fed. US MJ Laws to expect,

will KILL MJ THC Content Wellness Products !



MJNA’s “Cibaderm” is a Big Global Player NOVARTIS Brand ; Possible Lawsuits !!

According evidences MJNA Insisting on Old Well Known Brands from others !



Additionally as known the SEC also knocking at MJNA Doors !!

They Call That Inquiry When Doing Investigations ¨!!!

The SEC undercover investigate also Money- Laundering of

M. Llamas origin Money from his Ponzi- Scheme Money !!



MJNA & CANV & CannaBank Owner M. Llamas in Prison and M. Sides, Etc. next ??





As Investor if you may get or got harmed by any Short- Talk Blackmailing

or Misleading MB Members, just add www. to the Posts- Link to send and

File your Claims at ic3.gov CIA & FBI Branch - Internet Crimes, they help !



By The Company Abused, Mislead, Etc. ; Contact SEC Washington

To File Your Claims To Get Compensated !!

SEC Washington Hotline 202 551-6551 - Investors Protection

SEC Office Whistleblower at
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 45

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 182

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 121

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 105

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 104

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 140

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 98

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 97

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Stellantis NV: Short Interest Shift Sparks Investor Sentiment Questions

Updated Category News Views 299

Stellantis NV's (NYSE:STLA) short interest saw a notable drop of 13.81% since its last report, now standing at 44.96 million shares sold short, or about 1.56% of all tradable shares. Sounds like good news, right? But hang on—this isn't just a free pass to pop the champagne. When we talk short interest, we're peeling back layers on market sentiment that can turn on a...

Continue Reading
Minerals Technologies Showcases Innovative PFAS Solutions at Symposium

Updated Category News Views 185

Minerals Technologies to Present at Gabelli Funds PFAS Symposium Minerals Technologies Inc. (MTI) is thrilled to announce its participation in the upcoming PFAS Symposium hosted by Gabelli Funds. This notable event is set to take place in New York City, bringing together key figures in the industry to discuss significant advancements and novel strategies for tackling...

Continue Reading
Morning Market Insights for Key Stocks: A Daily Review

Updated Category News Views 338

Daily Market Insights: Leading Stocks to Watch Good morning, traders. Today’s notes zero in on SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA—names that tend to steer the broader tape. Our read on price comes from a blend of key levels shaped by price action, trading volume, and options flow. We refresh these levels daily and share them with Market Clubhouse...

Continue Reading
Exploring the Evolving Landscape of Electric Vehicles in the U.S.

Updated Category News Views 224

The Current State of Electric Vehicles in the U.S. The electric vehicle (EV) landscape in the U.S. is experiencing transformative changes. As the country marks significant milestones in EV deployment, there are noteworthy gaps in infrastructure and consumer attitudes that need addressing. The third annual HERE-SBD EV Index reveals how far the U.S. has come, yet highlights...

Continue Reading
eBay's Legal Victory: Dismissal of Harmful Product Claims

Updated Category News Views 173

eBay's legal drama hit the news when the U.S. government slammed them with a lawsuit accusing the online giant of violating the Clean Air Act back in 2024. The crux? Selling products that supposedly helped folks skirt around those pesky auto pollution controls. You know how it is—desks buzzing about regulatory risks, and traders getting twitchy over such moves. The...

Continue Reading